Cathay Biotech Inc. (SHA:688065)
43.19
-1.81 (-4.02%)
Jul 24, 2026, 3:00 PM CST
Cathay Biotech Market Cap
Cathay Biotech has a market cap or net worth of 31.13 billion as of July 24, 2026. Its market cap has decreased by -11.41% in one year.
Market Cap
31.13B
Enterprise Value
26.43B
Revenue
3.39B
Ranking
n/a
PE Ratio
52.39
Stock Price
43.19
ChartMarket Cap Chart
Since August 12, 2020, Cathay Biotech's market cap has decreased from 65.42B to 31.13B, a decrease of -52.42%. That is a compound annual growth rate of -11.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 31.13B | -13.27% |
| Dec 31, 2025 | 35.89B | 59.12% |
| Dec 31, 2024 | 22.56B | -29.54% |
| Dec 29, 2023 | 32.01B | -10.45% |
| Dec 30, 2022 | 35.75B | -53.44% |
| Dec 31, 2021 | 76.79B | 116.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Em Technology | 42.14B |
| Inner Mongolia Junzheng Energy & Chemical Group | 39.15B |
| Hoshine Silicon Industry | 37.74B |
| Zhejiang Sanmei Chemical Industry | 36.47B |
| Jiangsu Boqian New Materials Stock | 36.07B |
| Hubei Xingfa Chemicals Group | 35.43B |
| Do-Fluoride New Materials | 35.28B |
| Jinan Shengquan Group Share Holding | 31.82B |